Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#42 of 524)
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs: 1 blog
twitter: 25 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 37 Mendeley

Summary Blogs X Facebook Dimensions citations

So far, Altmetric has seen 1 blog post.

Comparatiu cost anàlisi de l'administració intravenosa i subcutània de rituximab en pacients amb limfoma

Infosalut, 20 Nov 2019

Els Serveis de Farmàcia i d'Hematologia de l'Hospital Universitari Son Espases han publicat un article comparant cost anàlisi…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.